Eysuvis Shortage Update: What Patients Need to Know in 2026

If you've been searching for Eysuvis at pharmacies in 2026, you may be wondering: is there actually a shortage? The short answer is no — there is no official FDA-listed shortage of Eysuvis as of 2026. But that doesn't tell the whole story. Many patients are still having trouble filling their prescriptions. Here's what's really going on.

Official Shortage Status: No FDA Shortage as of 2026

Eysuvis is not listed on the FDA's Drug Shortage Database as of 2026. Alcon Laboratories, which manufactures Eysuvis, has not declared a supply disruption. This means the product is being manufactured and distributed — but that doesn't mean every pharmacy has it in stock.

What Is a "Practical Shortage" and Why Does It Affect Eysuvis?

A practical shortage occurs when a drug is being produced but is difficult for patients to access due to market and distribution factors rather than a manufacturing crisis. For Eysuvis, several factors create this dynamic:

Brand-only status: No generic version exists, so there's no fallback option when pharmacies run low.

Niche demand: Eysuvis is prescribed for short-term use only, meaning individual patients need it infrequently. Many pharmacies don't stock it proactively.

Insurance barriers: Prior authorization requirements and high-tier formulary placement mean some patients abandon their prescriptions, further reducing demand signals to pharmacies.

Retail price: At $529–$687 per bottle without assistance programs, cost discourages fills and reduces pharmacy inventory turnover.

A Brief History of Eysuvis Availability

Eysuvis received FDA approval in October 2020 and launched commercially in January 2021. In its first four months, more than 11,600 prescriptions were filled. Coverage expanded significantly in early 2022, when UnitedHealthcare added it to commercial formularies and Cigna Medicare added it as a preferred brand — bringing coverage to about 118 million commercial lives and 7.1 million Medicare lives by mid-2022.

Kala Pharmaceuticals, the original developer, was later acquired, and the brand transitioned to Alcon Laboratories. This transition was smooth from a supply perspective, and Alcon has maintained commercial distribution without interruption. There have been no formal shortage declarations.

When Is Eysuvis Hardest to Find?

While there are no documented seasonal shortages of Eysuvis, patients often report difficulty finding it during certain periods:

Winter months, when dry indoor air from heating systems triggers more dry eye flares and increases demand.

Spring allergy season, when pollen and environmental allergens worsen dry eye symptoms.

In rural or smaller market areas, where independent pharmacies are less likely to stock niche ophthalmic medications.

What Patients Should Do Right Now

If you're struggling to fill your Eysuvis prescription, these steps are your best course of action:

Use medfinder to find which pharmacies near you have Eysuvis in stock today — medfinder calls pharmacies on your behalf and texts you the results.

Check BlinkRx (Alcon's home delivery pharmacy) — they specialize in Alcon products and often have reliable stock.

Apply for the Alcon Patient Access Program copay card — reduces cost to as little as $30 for insured patients.

Ask your prescriber about prior authorization — if your insurance requires PA, your doctor's office can often expedite approval.

Discuss alternatives with your ophthalmologist if you cannot access Eysuvis within a reasonable time.

The Bottom Line for 2026

There is no official FDA shortage of Eysuvis in 2026, and Alcon continues to manufacture and distribute the product. However, limited pharmacy stocking, brand-only status, and insurance barriers create real-world access challenges for many patients. With proactive strategies — especially using a tool like medfinder — most patients can get their prescription filled. See our complete guide to how to find Eysuvis in stock near you for step-by-step instructions.